185 related articles for article (PubMed ID: 23923018)
1. Do price subsidies on artemisinin combination therapy for malaria increase household use? Evidence from a repeated cross-sectional study in remote regions of Tanzania.
Cohen JL; Yadav P; Moucheraud C; Alphs S; Larson PS; Arkedis J; Massaga J; Sabot O
PLoS One; 2013; 8(7):e70713. PubMed ID: 23923018
[TBL] [Abstract][Full Text] [Related]
2. Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania.
Yadav P; Cohen JL; Alphs S; Arkedis J; Larson PS; Massaga J; Sabot O
Malar J; 2012 Aug; 11():299. PubMed ID: 22929587
[TBL] [Abstract][Full Text] [Related]
3. Subsidising artemisinin-based combination therapy in the private retail sector.
Opiyo N; Yamey G; Garner P
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009926. PubMed ID: 26954551
[TBL] [Abstract][Full Text] [Related]
4. Has Tanzania embraced the green leaf? Results from outlet and household surveys before and after implementation of the Affordable Medicines Facility-malaria.
Thomson R; Festo C; Johanes B; Kalolella A; Bruxvoort K; Nchimbi H; Tougher S; Cairns M; Taylor M; Kleinschmidt I; Ye Y; Mann A; Ren R; Willey B; Arnold F; Hanson K; Kachur SP; Goodman C
PLoS One; 2014; 9(5):e95607. PubMed ID: 24816649
[TBL] [Abstract][Full Text] [Related]
5. Effect of the Affordable Medicines Facility--malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data.
Tougher S; ; Ye Y; Amuasi JH; Kourgueni IA; Thomson R; Goodman C; Mann AG; Ren R; Willey BA; Adegoke CA; Amin A; Ansong D; Bruxvoort K; Diallo DA; Diap G; Festo C; Johanes B; Juma E; Kalolella A; Malam O; Mberu B; Ndiaye S; Nguah SB; Seydou M; Taylor M; Rueda ST; Wamukoya M; Arnold F; Hanson K
Lancet; 2012 Dec; 380(9857):1916-26. PubMed ID: 23122217
[TBL] [Abstract][Full Text] [Related]
6. Changes in the availability and affordability of subsidised artemisinin combination therapy in the private drug retail sector in rural Ghana: before and after the introduction of the AMFm subsidy.
Ansah EK; Whitty CJ; Bart-Plange C; Gyapong M
Int Health; 2016 Nov; 8(6):427-432. PubMed ID: 27744327
[TBL] [Abstract][Full Text] [Related]
7. What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism.
; Tougher S; Hanson K; Goodman C
Malar J; 2017 Apr; 16(1):173. PubMed ID: 28441956
[TBL] [Abstract][Full Text] [Related]
8. Access to subsidized ACT and malaria treatment--evidence from the first year of the AMFm program in six districts in Uganda.
Fink G; Dickens WT; Jordan M; Cohen JL
Health Policy Plan; 2014 Jul; 29(4):517-27. PubMed ID: 23783833
[TBL] [Abstract][Full Text] [Related]
9. Price subsidies increase the use of private sector ACTs: evidence from a systematic review.
Morris A; Ward A; Moonen B; Sabot O; Cohen JM
Health Policy Plan; 2015 Apr; 30(3):397-405. PubMed ID: 24633915
[TBL] [Abstract][Full Text] [Related]
10. The Affordable Medicines Facility-malaria (AMFm): are remote areas benefiting from the intervention?
Ye Y; Arnold F; Noor A; Wamukoya M; Amuasi J; Blay S; Mberu B; Ren R; Kyobutungi C; Wekesah F; Gatakaa H; Toda M; Njogu J; Evance I; O'Connell K; Shewchuk T; Thougher S; Mann A; Willey B; Goodman C; Hanson K
Malar J; 2015 Oct; 14():398. PubMed ID: 26452625
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of malaria parasitemia and purchase of artemisinin-based combination therapies (ACTs) among drug shop clients in two regions in Tanzania with ACT subsidies.
Briggs MA; Kalolella A; Bruxvoort K; Wiegand R; Lopez G; Festo C; Lyaruu P; Kenani M; Abdulla S; Goodman C; Kachur SP
PLoS One; 2014; 9(4):e94074. PubMed ID: 24732258
[TBL] [Abstract][Full Text] [Related]
12. Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries.
Davis B; Ladner J; Sams K; Tekinturhan E; de Korte D; Saba J
Malar J; 2013 Apr; 12():135. PubMed ID: 23607504
[TBL] [Abstract][Full Text] [Related]
13. The quest for universal access to effective malaria treatment: how can the AMFm contribute?
Matowe L; Adeyi O
Malar J; 2010 Oct; 9():274. PubMed ID: 20932286
[TBL] [Abstract][Full Text] [Related]
14. Expanding access to parasite-based malaria diagnosis through retail drug shops in Tanzania: evidence from a randomized trial and implications for treatment.
Maloney K; Ward A; Krenz B; Petty N; Bryson L; Dolkart C; Visser T; Le Menach A; Scott VK; Cohen JM; Mtumbuka E; Mkude S
Malar J; 2017 Jan; 16(1):6. PubMed ID: 28049481
[TBL] [Abstract][Full Text] [Related]
15. Insights into the Affordable Medicines Facility-malaria in Ghana: the role of caregivers and licensed chemical sellers in four regions.
Adjei AA; Winch P; Laar A; Sullivan DJ; Sakyi KS; Stephens JK; Adjei GO; Boateng IA; Aubyn VN; Kubio C; Tuakli J; Vanotoo L; Bortei BB; Amo-Addae M; Sorvor F; Coleman N; Dalglish S; Owusu R; Gebreyesus T; Essuman E; Greene R; Ankomah E; Houston K; Bart-Plange C; Salamat S; Addison EA; Quakyi IA
Malar J; 2016 May; 15(1):263. PubMed ID: 27160685
[TBL] [Abstract][Full Text] [Related]
16. The Affordable Medicines Facility-malaria--a success in peril.
Talisuna AO; Adibaku S; Amojah CN; Amofah GK; Aubyn V; Dodoo A; Juma E; Jackou DH; Mkude S; Okui AP; Ramarosandratana B; Shija SJ
Malar J; 2012 Nov; 11():370. PubMed ID: 23137141
[TBL] [Abstract][Full Text] [Related]
17. Improving rational use of ACTs through diagnosis-dependent subsidies: Evidence from a cluster-randomized controlled trial in western Kenya.
Prudhomme O'Meara W; Menya D; Laktabai J; Platt A; Saran I; Maffioli E; Kipkoech J; Mohanan M; Turner EL
PLoS Med; 2018 Jul; 15(7):e1002607. PubMed ID: 30016316
[TBL] [Abstract][Full Text] [Related]
18. Accessibility, availability and affordability of anti-malarials in a rural district in Kenya after implementation of a national subsidy scheme.
Smith N; Obala A; Simiyu C; Menya D; Khwa-Otsyula B; O'Meara WP
Malar J; 2011 Oct; 10():316. PubMed ID: 22029829
[TBL] [Abstract][Full Text] [Related]
19. Improving access to malaria medicine through private-sector subsidies in seven African countries.
Tougher S; Mann AG; ; Ye Y; Kourgueni IA; Thomson R; Amuasi JH; Ren R; Willey BA; Ansong D; Bruxvoort K; Diap G; Festo C; Johanes B; Kalolella A; Mallam O; Mberu B; Ndiaye S; Nguah SB; Seydou M; Taylor M; Wamukoya M; Arnold F; Hanson K; Goodman C
Health Aff (Millwood); 2014 Sep; 33(9):1576-85. PubMed ID: 25201662
[TBL] [Abstract][Full Text] [Related]
20. An assessment of the malaria-related knowledge and practices of Tanzania's drug retailers: exploring the impact of drug store accreditation.
Thomson R; Johanes B; Festo C; Kalolella A; Taylor M; Tougher S; Ye Y; Mann A; Ren R; Bruxvoort K; Willey B; Arnold F; Hanson K; Goodman C
BMC Health Serv Res; 2018 Mar; 18(1):169. PubMed ID: 29523139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
